article
<bold>Background:</bold> Proportional assist ventilation (PAV) is a physiological ventilation mode with better patient ventilator synchrony. However its role in intubated patients with chronic obstructive pulmonary disease (COPD) is still not well defined. <bold>Objective:</bold> To evaluate the efficacy of PAV mode in intubated patients with COPD exacerbation in comparison with conventional synchronized intermittent mandatory ventilation (SIMV) mode. <bold>Patients & methods:</bold> Fifty COPD patients presented with hypercapnic respiratory failure who are intubated and ventilated were recruited to the study. After 12 h of assist-control ventilation, 25 patients shifted to SIMV mode (group I) while the other 25 patients shifted to PAV mode (group II). Vital signs, gasometric and mechanical parameters, duration of ventilation and intensive care unit (ICU) stay were measured. <bold>Results:</bold> The successful outcome was achieved in 76.0% in group I versus 72.0% in group II. Comparison between the two groups after 24 h of ventilation showed significantly higher values in the PAV group for respiratory rate, heart rate, and systolic blood pressure (P < 0.001).Significantly lower pH (P <0.01), higher partial arterial carbon dioxide pressure (PaCO<sub>2</sub>)(P <0.001), significantly lower tidal volume, peak inspiratory pressure, missing efforts, inspiratory time over total time (Ti/Ttot).A shorter duration of ventilation and ICU stay were observed in the PAV group (P < 0.01 for each). <bold>Conclusion:</bold> PAV can maintain improvement of clinical, gasometric and ventilator parameters in intubated COPD patients with the advantages of shorter duration of ventilation and hospitalization compared with SIMV.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1183/23120541.rfmv-2024.119
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.